Brainstorm Cell Therapeutics enters warrant inducement deal for ~$1.64M gross proceeds

BRAINSTORM CELL THERAPEUTICS INC.

Holder to exercise existing warrants for 1,381,383 shares; new warrants at 200% of exercised shares.
New warrants have $1.19 exercise price, exercisable after stockholder approval, 5-year term.
Gross proceeds ~$1.64M; net proceeds for working capital and general corporate purposes.
Maxim Group acting as inducement agent with 6% cash fee and $12,500 expenses.
Company must seek stockholder approval within 90 days; resale registration statement to be filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.